The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.
Imetelstat Clinical Trial reaches milestone
playtowin59
CSN Member Posts: 3
Hi all:
I mentioned in previous posts that I would let you know of the progress of the clinical trials.
Geron has announced that the clinical trial for metastatic BC has completed its enrollment goal ahead of schedule. Additional trials are underway for brain mets, nsclc and others.
See link:
http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-newsArticle&ID=1656213&highlight=
From the release:
"This Phase 2 study enrolled in just over a year, ahead of our expectations, attesting to the need for effective treatments for metastatic breast cancer and driven by the interest among clinical investigators for compounds with novel mechanisms of action against new targets," said Stephen M. Kelsey, M.D., Geron's Executive Vice President, Head of R&D and Chief Medical Officer. "We continue to expect to report top-line results from this trial by the end of Q4 2012, provided a sufficient number of progression events have accrued in order to estimate the progression-free survival for patients receiving imetelstat in addition to standard of care. Currently, we believe an improvement of approximately three months in PFS over standard of care, assuming a representative patient population was enrolled, would be consistent with a clinical benefit."
Other clinical trials include can be found at
http://clinicaltrials.gov/ct2/results?term=geron
some of which are
GRN1005 -- metastasis of BC to brain
GRN1005 -- Metastasis of NSCLC to brain
Imetelstat -- NSCLC
Imetelstat -- Brain tumors in young people
Best of Healthy Wishes to all
Dave
A search in Inspire's (inspire.com) "find it" for Imetelstat will identify past information on this new and exciting treatment regimen.
I mentioned in previous posts that I would let you know of the progress of the clinical trials.
Geron has announced that the clinical trial for metastatic BC has completed its enrollment goal ahead of schedule. Additional trials are underway for brain mets, nsclc and others.
See link:
http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-newsArticle&ID=1656213&highlight=
From the release:
"This Phase 2 study enrolled in just over a year, ahead of our expectations, attesting to the need for effective treatments for metastatic breast cancer and driven by the interest among clinical investigators for compounds with novel mechanisms of action against new targets," said Stephen M. Kelsey, M.D., Geron's Executive Vice President, Head of R&D and Chief Medical Officer. "We continue to expect to report top-line results from this trial by the end of Q4 2012, provided a sufficient number of progression events have accrued in order to estimate the progression-free survival for patients receiving imetelstat in addition to standard of care. Currently, we believe an improvement of approximately three months in PFS over standard of care, assuming a representative patient population was enrolled, would be consistent with a clinical benefit."
Other clinical trials include can be found at
http://clinicaltrials.gov/ct2/results?term=geron
some of which are
GRN1005 -- metastasis of BC to brain
GRN1005 -- Metastasis of NSCLC to brain
Imetelstat -- NSCLC
Imetelstat -- Brain tumors in young people
Best of Healthy Wishes to all
Dave
A search in Inspire's (inspire.com) "find it" for Imetelstat will identify past information on this new and exciting treatment regimen.
Discussion Boards
- All Discussion Boards
- 7 Cancer Survivors Network Information
- 6 Welcome to CSN
- 1 CSN Update
- 122.7K Cancer specific
- 2.8K Anal Cancer
- 457 Bladder Cancer
- 311 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 410 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 682 Leukemia
- 805 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 243 Multiple Myeloma
- 7.2K Ovarian Cancer
- 71 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.7K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 745 Skin Cancer
- 662 Stomach Cancer
- 194 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.5K Lifestyle Discussion Boards